synthetic oligonucleotides
Maravai LifeSciences Acquires Nucleotide Maker MyChem for at Least $240M
MyChem provides modified nucleotides and other chemicals used in mRNA synthesis for the diagnostics, pharmaceutical, genomics, and research markets.